IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release
- 1 September 2001
- journal article
- case report
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 119 (1) , 114-123
- https://doi.org/10.1016/s0165-5728(01)00373-3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Anti-GQ1b antibodies and evoked acetylcholine release at mouse motor endplatesMuscle & Nerve, 2000
- Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blockerMuscle & Nerve, 2000
- Neuromuscular blockade by IgG antibodies from patients with Guillain‐Barré syndrome: A macro‐patch‐clamp studyAnnals of Neurology, 1998
- Antiglycolipid Antibodies in Motor NeuropathiesaAnnals of the New York Academy of Sciences, 1998
- Gangliosides and Sialylcholesterol as Modulators of Synaptic FunctionsaAnnals of the New York Academy of Sciences, 1998
- Endogenous ganglioside GM1 modulates L-type calcium channel activity in N18 neuroblastoma cellsJournal of Neuroscience, 1994
- Acute conduction block in vitro following exposure to antiganglioside seraMuscle & Nerve, 1993
- Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b gangliosideAnnals of Neurology, 1992
- Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndromeAnnals of Neurology, 1992
- Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction.Proceedings of the National Academy of Sciences, 1991